Combination chemotherapy has been the standard treatment for advanced-stage Hodgkin’s lymphoma for decades. Chemotherapy backbones differ worldwide, with doxorubicin, bleomycin, vinblastine, and ...
An immunotherapy approach to treating advanced Hodgkin lymphoma may drastically increase patients’ chances of survival, including those as young as 12, according to a new clinical trial.
In patients with advanced Hodgkin’s lymphoma, adding brentuximab vedotin to chemotherapy improves outcomes, but challenges remain. New research findings on nivolumab plus chemotherapy in these ...
The rate of non-Hodgkin's lymphoma has nearly doubled since the 1970s, but advances in treatments are offering new hope. Laura Colton Tepper had just endured her second round of chemotherapy for ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.